Literature DB >> 16357534

Dual-color-coded imaging of viable circulating prostate carcinoma cells reveals genetic exchange between tumor cells in vivo, contributing to highly metastatic phenotypes.

Gennadi V Glinsky1, Anna B Glinskii, Olga Berezovskaya, Brian A Smith, Ping Jiang, Xiao-Ming Li, Meng Yang, Robert M Hoffman.   

Abstract

Color-coded imaging analysis revealed yellow fluorescent metastasis precursor cells that were readily recognized in the blood of tumor-bearing mice after mixtures of red fluorescent protein (RFP)- and green fluorescent protein (GFP)-expressing PC-3 human prostate carcinoma cells were implanted in the nude mouse prostate and metastasized. The yellow fluorescent cells were purified from the blood of nude mice to 99% homogeneity by FACS, expanded in culture, and reimplanted in the prostate of nude mice. The yellow fluorescent phenotype was heritable and stably maintained by tumor cells for many generations in vitro and in vivo. In the animals implanted with the yellow-fluorescing cells, 100% developed aggressive metastatic cancer. Lung metastases were demonstrated in 100% of the animals as early as four weeks after injection of the yellow-fluorescing cells in the mouse prostate. In contrast, when the GFP- and RFP-expressing parental cells were inoculated into the mouse prostate separately, none of the animals developed lung metastasis. All animals had almost exclusively yellow fluorescent cells in the blood and bone marrow. These results are consistent with the idea that spontaneous genetic exchange between tumor cells in vivo contributes to genomic instability and creation of highly metastatic cells.

Entities:  

Mesh:

Year:  2006        PMID: 16357534     DOI: 10.4161/cc.5.2.2320

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

1.  Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma.

Authors:  Philip C Gach; Peter J Attayek; Rebecca L Whittlesey; Jen Jen Yeh; Nancy L Allbritton
Journal:  Biosens Bioelectron       Date:  2013-11-18       Impact factor: 10.618

2.  Orthotopic mouse models of tumor metastasis expressing fluorescent reporters produce imageable circulating tumor cells.

Authors:  Robert M Hoffman
Journal:  Cancer Microenviron       Date:  2014-11-23

3.  Combined fluorescence and X-Ray tomography for quantitative in vivo detection of fluorophore.

Authors:  W C Barber; Y Lin; O Nalcioglu; J S Iwanczyk; N E Hartsough; G Gulsen
Journal:  Technol Cancer Res Treat       Date:  2010-02

Review 4.  Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins.

Authors:  Robert M Hoffman
Journal:  Clin Exp Metastasis       Date:  2008-09-12       Impact factor: 5.150

5.  Color-coded imaging of splenocyte-pancreatic cancer cell interactions in the tumor microenvironment.

Authors:  Michele McElroy; Sharmeela Kaushal; Michael Bouvet; Robert M Hoffman
Journal:  Cell Cycle       Date:  2008-09-26       Impact factor: 4.534

6.  Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens.

Authors:  Atsushi Suetsugu; Matthew Katz; Jason Fleming; Mark Truty; Ryan Thomas; Hisataka Moriwaki; Michael Bouvet; Shigetoyo Saji; Robert M Hoffman
Journal:  J Cell Biochem       Date:  2012-07       Impact factor: 4.429

7.  Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.

Authors:  J Akech; J J Wixted; K Bedard; M van der Deen; S Hussain; T A Guise; A J van Wijnen; J L Stein; L R Languino; D C Altieri; J Pratap; E Keller; G S Stein; J B Lian
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867

8.  RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.

Authors:  Ohad Tarcic; Roy Z Granit; Ioannis S Pateras; Hadas Masury; Bella Maly; Yaara Zwang; Yosef Yarden; Vassilis G Gorgoulis; Eli Pikarsky; Ittai Ben-Porath; Moshe Oren
Journal:  Cell Death Differ       Date:  2017-02-03       Impact factor: 15.828

9.  Suppression of cancer progression by MGAT1 shRNA knockdown.

Authors:  Reza Beheshti Zavareh; Mahadeo A Sukhai; Rose Hurren; Marcela Gronda; Xiaoming Wang; Craig D Simpson; Neil Maclean; Francis Zih; Troy Ketela; Carol J Swallow; Jason Moffat; David R Rose; Harry Schachter; Aaron D Schimmer; James W Dennis
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

Review 10.  Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers.

Authors:  Gennadi V Glinsky
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 6.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.